Glassman Wealth Services’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14
Closed -$303 1500
2023
Q4
$303 Sell
14
-63
-82% -$1.25K ﹤0.01% 1820
2023
Q3
$1.58K Buy
+77
New +$2.22K ﹤0.01% 1406
2022
Q1
Sell
-301
Closed -$13K 1904
2021
Q4
$13K Buy
301
+252
+514% +$10.6K ﹤0.01% 722
2021
Q3
$2K Sell
49
-78
-61% -$3.58K ﹤0.01% 1214
2021
Q2
$7K Buy
127
+2
+2% +$141 ﹤0.01% 843
2021
Q1
$9K Hold
125
﹤0.01% 743
2020
Q4
$11K Buy
125
+80
+178% +$5.9K ﹤0.01% 692
2020
Q3
$3K Hold
45
﹤0.01% 921
2020
Q2
$2K Buy
45
+22
+96% +$798 ﹤0.01% 892
2020
Q1
$1K Buy
23
+20
+667% +$1.16K ﹤0.01% 975
2019
Q4
$0 Buy
+3
New +$369 ﹤0.01% 1441
2019
Q3
Sell
-9
Closed -$2K 1335
2019
Q2
$2K Buy
+9
New +$1.54K ﹤0.01% 744

Other funds holding SAGE